Long-term survivors in glioblastoma patients homogeneously treated with the Stupp regimen, clinical characteristics and MGMT status: Initial results from the GLIOCAT study

Authors :: Núria de la Iglesia
Teresa Ribalta
Laura Oleaga
Maria Elena Martinez
Francesc Alameda
Estela Pineda
N. García
Carlos Mesia
Carmen Balana
Anna Estival
Sira Domenech
Teresa Pujol
Eugenia Verger
Jaume Capellades
Oscar Gallego
Miguel Gil
J.M. Velarde
Rafel Fuentes
Cristina Carrato
Source :: Journal of Clinical Oncology. 34:e13513-e13513
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e13513Background: Prognosis of GBM pts is still poor with a median survival of 15 months; however a small fraction survives more than 30 months, defined in our study as long term survivors (LTS-30)...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
Surgery
Term (time)
Regimen
Internal medicine
medicine
business
Median survival
Glioblastoma

Full Text Access

Tools